Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach.
暂无分享,去创建一个
[1] M. Janssen-Heijnen,et al. Co‐morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer , 2005, The British journal of surgery.
[2] J. Coebergh,et al. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. , 2005, European journal of cancer.
[3] J. Coebergh,et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. , 2005, European journal of cancer.
[4] R. Govindan,et al. Differential prognostic impact of comorbidity. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] J. Coebergh,et al. Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study , 2004, European journal of gastroenterology & hepatology.
[6] J. Coebergh,et al. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer , 2004, Thorax.
[7] Edward L Spitznagel,et al. Prognostic importance of comorbidity in a hospital-based cancer registry. , 2004, JAMA.
[8] J. Coebergh,et al. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients , 2004, British Journal of Cancer.
[9] A. Zaslavsky,et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] Michael Simoff,et al. Impact of comorbidity on lung cancer survival , 2003, International journal of cancer.
[11] E. Gore,et al. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. , 2002, International journal of radiation oncology, biology, physics.
[12] M. Bousamra,et al. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.
[13] J. Piccirillo,et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. , 2002, The Journal of thoracic and cardiovascular surgery.
[14] W. Gianni,et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[16] P. Alken,et al. The Difficult Stone Case: Definition and Management , 2001, European Urology.
[17] J. Birkmeyer,et al. Operative mortality with elective surgery in older adults. , 2001, Effective clinical practice : ECP.
[18] M. Janssen-Heijnen,et al. The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population‐based study , 2001, BJU international.
[19] R. Yancik,et al. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Piccirillo,et al. Importance of Comorbidity in Head and Neck Cancer , 2000, The Laryngoscope.
[21] Kil,et al. Comorbidity in patients with prostate cancer and its relevance to treatment choice , 1999, BJU international.
[22] A S Kosinski,et al. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. , 1999, Journal of clinical epidemiology.
[23] D. Kerr,et al. Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group. , 1998, European journal of cancer.
[24] J. Coebergh,et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. , 1998, Lung cancer.
[25] G. Lyman,et al. Comorbidity and functional status are independent in older cancer patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Jager,et al. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] H. Adami,et al. International renal‐cell cancer study. VIII. Role of diuretics, other anti‐hypertensive medications and hypertension , 1995, International journal of cancer.
[28] C. Bolliger,et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. , 1995, American journal of respiratory and critical care medicine.
[29] W. Forman. The role of chemotherapy and adjuvant therapy in the management of colorectal cancer , 1994, Cancer.
[30] D. Trichopoulos,et al. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma , 1993, Cancer Causes & Control.
[31] Sati Mazumdar,et al. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale , 1992, Psychiatry Research.
[32] F Parazzini,et al. The epidemiology of endometrial cancer. , 1991, Gynecologic oncology.
[33] A. Miller,et al. Coffee and alcohol as determinants of risk of pancreas cancer: A case‐control study from toronto , 1991, International journal of cancer.
[34] A. Feinstein,et al. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. , 1974, Journal of chronic diseases.
[35] A. Wolk,et al. The role of diabetes mellitus in the aetiology of renal cell cancer , 1999, Diabetologia.
[36] R. Damhuis,et al. Resection rates and postoperative mortality in 7,899 patients with lung cancer. , 1996, The European respiratory journal.
[37] N. Petrelli,et al. Age and sex are independent predictors of 5‐fluorouracil toxicity. Analysis of a large scale phase III trial , 1995, Cancer.
[38] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[39] T. Hakulinen,et al. A computer program package for relative survival analysis. , 1985, Computer programs in biomedicine.